A study investigating how type I IFNs affect the metabolic state of CD8+ T cells in SLE patients reported that the downregulation of mitochondria-derived genes and mitochondria-associated metabolic pathways was associated with a high type I IFN signature in lupus patients [52]. The gene discussed is CD8A; the disease is systemic lupus erythematosus.